Acrux Limited News - ACR

Acrux Limited crash over patent problems

/newsletter/barneyc/637/acrux-limited-crash-over-patent-problems

Should you invest in Acrux Limited?

/newsletter/barneyc/580/should-you-invest-in-acrux-limited

Here’s why you should avoid Australia’s biotechnology sector

http://www.fool.com.au/2015/03/17/heres-why-you-should-avoid-australias-biotechnology-sector/

Acrux Announces Successful AXIRON™ Phase III Trial Results

Australian company, Acrux, today announced positive results from a Phase III trial evaluating the safety and efficacy of AXIRON™...

Acrux to Start USA Trial of Its Unique Testosterone Lotion For Men

Acrux (ASX: ACR): ? -- Phase 2 trial under US IND starting in October 2006 ? -- US Market research shows strong patient preference for Acrux...

Acrux Acquires Rights to Commercialise World's First Contraceptive Spray; New-Generation Contraceptive Licensed from Population

Annual Worldwide Sales of Hormonal Contraceptives Exceed US$4 Billion ? Acrux (ASX: ACR), the Australian company with...

Acrux Acquires Rights to Commercialise World's First Contraceptive Spray; New-Generation Contraceptive Licensed from Population

Annual Worldwide Sales of Hormonal Contraceptives Exceed US$4 Billion ? Acrux (ASX: ACR), the Australian company with...

Acrux's Igor Gonda and Nina Wilkins Join Experts on Pain and Reproductive Health Panels At BIO CEO

Acrux Limited (ASX: ACR), a Melbourne, Australia-based pharmaceutical company which has developed an innovative transdermal drug delivery system...

Trading Statement

RNS Number:6473U Abbeycrest PLC 27 January 2004 For Immediate Release 27 January, 2004 Abbeycrest Plc Trading Update...

Trading Update

RNS Number:4936U Abbeycrest PLC 21 January 2004 For Immediate Release 21 January, 2004 Notice of Christmas Trading Update...

Interim Results

RNS Number:4254S Abbeycrest PLC 25 November 2003 For Immediate Release 7.00am 25 November, 2003 Interim Results for the six...

Notice of Results

RNS Number:0255R Abbeycrest PLC 17 October 2003 For Immediate Release 17 October 2003 Notice of results /Directors Declaration...

Directorate Change

RNS Number:7324Q Abbeycrest PLC 09 October 2003 For Immediate Release 9 October 2003 Board Change Abbeycrest Plc, the...

Director Shareholding

RNS Number:5682O Abbeycrest PLC 12 August 2003 Abbeycrest Plc 12 August 2003 Abbeycrest Plc announces that Michael Lever, Chairman and...

AGM Statement

RNS Number:6261N Abbeycrest PLC 16 July 2003 For Immediate Release Wednesday, 16th July 2003 Chairman's AGM Statement Abbeycrest...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Acrux Limited (ACR)

Empower your portfolio: Real-time discussions and actionable trading ideas.

ACR News

Acrux Limited crash over patent problems

Should you invest in Acrux Limited?

Here’s why you should avoid Australia’s biotechnology sector

Acrux Announces Successful AXIRON™ Phase III Trial Results

Acrux to Start USA Trial of Its Unique Testosterone Lotion For Men

Acrux Acquires Rights to Commercialise World's First Contraceptive Spray; New-Generation Contraceptive Licensed from Population

Acrux Acquires Rights to Commercialise World's First Contraceptive Spray; New-Generation Contraceptive Licensed from Population

Acrux's Igor Gonda and Nina Wilkins Join Experts on Pain and Reproductive Health Panels At BIO CEO

Trading Statement

Trading Update

Interim Results

Notice of Results

Directorate Change

Director Shareholding

AGM Statement

ACR Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Acrux Limited (ACR) News

Acrux Limited (ACR)

Empower your portfolio: Real-time discussions and actionable trading ideas.

ACR News

Acrux Limited crash over patent problems

Should you invest in Acrux Limited?

Here’s why you should avoid Australia’s biotechnology sector

Acrux Announces Successful AXIRON™ Phase III Trial Results

Acrux to Start USA Trial of Its Unique Testosterone Lotion For Men

Acrux Acquires Rights to Commercialise World's First Contraceptive Spray; New-Generation Contraceptive Licensed from Population

Acrux Acquires Rights to Commercialise World's First Contraceptive Spray; New-Generation Contraceptive Licensed from Population

Acrux's Igor Gonda and Nina Wilkins Join Experts on Pain and Reproductive Health Panels At BIO CEO

Trading Statement

Trading Update

Interim Results

Notice of Results

Directorate Change

Director Shareholding

AGM Statement

ACR Discussion

Your Recent History